Innovative Technology Improves Detection of Bladder Cancer

摘要

Washington, D.C. - MedStar Washington Hospital Center now offers Blue Light Cystoscopy with Cysview~R, a new, FDA-approved technology used to pinpoint bladder tumours in patients with known or suspected bladder cancer."Detecting bladder cancer in its earliest stage is sometimes difficult, and an inaccurate diagnosis can result in incomplete treatment, which translates into the potential for cancer progression and delays in treatment," said Lambros Stamatakis, MD, director of Urologic Oncology at MedStar Washington Hospital Center. "Blue Light Cystoscopy with Cysview can provide a more accurate diagnosis of bladder tumors compared to the standard technique, which can overlook some tumours that are too small to see."